Evaluation of Patients Receiving High-flow Nasal Cannula Oxygenation Therapy in a Pediatric Intensive Care Unit
PDF
Cite
Share
Request
Original Research
P: 17-24
March 2022

Evaluation of Patients Receiving High-flow Nasal Cannula Oxygenation Therapy in a Pediatric Intensive Care Unit

J Turk Soc Intens Care 2022;20(1):17-24
1. Sağlık Bilimleri Üniversitesi, Adana Şehir Eğitim ve Araştırma Hastanesi, Çocuk Sağlığı ve Hastalıkları Kliniği, Adana, Türkiye
2. Adana Şehir Eğitim ve Araştırma Hastanesi, Çocuk Sağlığı ve Hastalıkları Kliniği, Adana, Türkiye
No information available.
No information available
Received Date: 30.09.2019
Accepted Date: 24.10.2019
Publish Date: 02.03.2022
PDF
Cite
Share
Request

ABSTRACT

Objective:

Patients hospitalized in pediatric intensive care units require various rates of respiratory and oxygen support therapies. Invasive and non-invasive treatment methods are used as respiratory support treatment, and new technologies are being used in oxygen delivery systems. This study aimed to investigate the success and complication rates of high flow nasal cannula oxygen (HFNCO) therapy in the pediatric intensive care unit.

Materials and Methods:

In this study, demographic characteristics, treatment processes and success/complication rates of the patients treated with HFNCO between 01.02.2018 and 01.02.2019 in the pediatric intensive care unit of Pediatric Clinic of University of Health Sciences Turkey, Adana City Training and Research Hospital were evaluated retrospectively.

Results:

The mean age of 131 patients included in the study was 41.82±46.88 months. The indications for hospitalization of the patients to pediatric intensive care unit or the reasons for starting HFNCO treatment were as follows: pneumonia in 59.5%, asthma/bronchiolitis in 14.5%, sepsis in 6.9%, post-extubation stridor/respiratory distress in 16.8% and other causes in 2.3%. HFNCO treatment was evaluated as successful in 90.8% of the patients and unsuccessful in 9.2%. Complications were seen in five patients (3.8%), pneumothorax in four patients, and abdominal distension in one patient.

Conclusion:

Studies on HFNCO therapy in terms of therapeutic efficacy, safety, and indications for use are not yet sufficient in quantity and terms of scientific evidence. To evaluate the efficacy and complications of HFNCO treatment, multicenter randomized controlled trials are needed in different patient groups.

Keywords: Pediatric intensive care, complication, high flow nasal cannula oxygenation, mortality

References

1
Walls R, Hockberger R, Gausche-HilL M. Rosen’s Emergency Medicine: Concepts and Clinical Practice, 9th Ed., Philedelphia: Elsevier; 2018; p. 25-33.
2
Ashraf-Kashani N, Kumar R. High-flow nasal oxygen therapy. BJA Education 2017;17:63-7.
3
Cummings JJ, Polin RA; Committee on Fetus and Newborn, American Academy of Pediatrics. Noninvasive Respiratory Support. Pediatrics 2016;137.
4
Wing R, James C, Maranda LS, Armsby CC. Use of high-flow nasal cannula support in the emergency department reduces the need for intubation in pediatric acute respiratory insufficiency. Pediatr Emerg Care 2012;28:1117-23.
5
Lee JH, Rehder KJ, Williford L, Cheifetz IM, Turner DA. Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature. Intensive Care Med 2013;39:247-57.
6
Köksoy ÖT, Paksu MŞ, Yener N, Kaplan EM. Non-Invasive Mechanical Ventilation Practice in Pediatric Intensive Care Unit: A Retrospective Study. J Pediatr Emerg Intensive Care Med 2016;3:62-8.
7
Yang CY, Yang MC, Chu SM, Chiang MC, Lien R. A randomized pilot study comparing the role of PEEP, O2 flow, and high-flow air for weaning of ventilatory support in very low birth weight infants. Pediatr Neonatol 2018;59:198-204.
8
Riese J, Fierce J, Riese A, Alverson BK. Effect of a Hospital-wide High-Flow Nasal Cannula Protocol on Clinical Outcomes and Resource Utilization of Bronchiolitis Patients Admitted to the PICU. Hosp Pediatr 2015;5:613-8.
9
Milani GP, Plebani AM, Arturi E, Brusa D, Esposito S, Dell’Era L, et al. Using a high-flow nasal cannula provided superior results to low-flow oxygen delivery in moderate to severe bronchiolitis. Acta Paediatr 2016;105:e368-72.
10
Lodeserto FJ, Lettich TM, Rezaie SR. High-flow Nasal Cannula: Mechanisms of Action and Adult and Pediatric Indications. Cureus 2018;10:e3639.
11
Shein SL, Slain KN, Rotta AT. High Flow Nasal Cannula Flow Rates: New Data Worth the Weight. J Pediatr 2017;189:9-10.
12
Yaman A, Kendirli T, Ödek Ç, Ateş C, Taşyapar N, Güneş M, et al. Efficacy of noninvasive mechanical ventilation in prevention of intubation and reintubation in the pediatric intensive care unit. J Crit Care 2016;32:175-81.
13
Can FK, Anil AB, Anil M, Zengin N, Bal A, Bicilioglu Y, et al. Impact of High-flow Nasal Cannula Therapy in Quality Improvement and Clinical Outcomes in a Non-invasive Ventilation Device-free Pediatric Intensive Care Unit. Indian Pediatr 2017;54:835-40.
14
Kawaguchi A, Yasui Y, deCaen A, Garros D. The Clinical Impact of Heated Humidified High-Flow Nasal Cannula on Pediatric Respiratory Distress. Pediatr Crit Care Med 2017;18:112-9.
15
Slain KN, Martinez-Schlurmann N, Shein SL, Stormorken A. Nutrition and High-Flow Nasal Cannula Respiratory Support in Children With Bronchiolitis. Hosp Pediatr 2017;7:256-62.
16
Konca Ç, Apaydın HÖ, Geyik M. A Case of Pneumothorax due to High-Flow Nasal Cannula Oxygen Therapy. J Pediatr Emerg Intensive Care Med 2017;4:80-3.
17
Schmid F, Olbertz DM, Ballmann M. The use of high-flow nasal cannula (HFNC) as respiratory support in neonatal and pediatric intensive care units in Germany - A nationwide survey. Respir Med 2017;131:210-4.
18
Testa G, Iodice F, Ricci Z, Vitale V, De Razza F, Haiberger R, et al. Comparative evaluation of high-flow nasal cannula and conventional oxygen therapy in paediatric cardiac surgical patients: a randomized controlled trial. Interact Cardiovasc Thorac Surg 2014;19:456-61.
19
Beggs S, Wong ZH, Kaul S, Ogden KJ, Walters JA. High-flow nasal cannula therapy for infants with bronchiolitis. Cochrane Database Syst Rev 2014;CD009609.
20
Milési C, Boubal M, Jacquot A, Baleine J, Durand S, Odena MP, et al. High-flow nasal cannula: recommendations for daily practice in pediatrics. Ann Intensive Care 2014;4:29.
21
ten Brink F, Duke T, Evans J. High-flow nasal prong oxygen therapy or nasopharyngeal continuous positive airway pressure for children with moderate-to-severe respiratory distress?*. Pediatr Crit Care Med 2013;14:e326-31.
22
Long E, Babl FE, Duke T. Is there a role for humidified heated high-flow nasal cannula therapy in paediatric emergency departments? Emerg Med J 2016;33:386-9.
23
Hegde S, Prodhan P. Serious air leak syndrome complicating high-flow nasal cannula therapy: a report of 3 cases. Pediatrics 2013;131:e939-44.
24
Locke RG, Wolfson MR, Shaffer TH, Rubenstein SD, Greenspan JS. Inadvertent administration of positive end-distending pressure during nasal cannula flow. Pediatrics 1993;91:135-8.
25
Kallappa C, Hufton M, Millen G, Ninan TK. Use of high flow nasal cannula oxygen (HFNCO) in infants with bronchiolitis on a paediatric ward: a 3-year experience. Arch Dis Child 2014;99:790-1.
26
Oto A, Erdoğan S, Boşnak M. Oxygen therapy via high flow nasal cannula in pediatric intensive care unit. Turk J Pediatr 2016;58:377-82.
27
Wraight TI, Ganu SS. High-flow nasal cannula use in a paediatric intensive care unit over 3 years. Crit Care Resusc 2015;17:197-201.
28
Kelly GS, Simon HK, Sturm JJ. High-flow nasal cannula use in children with respiratory distress in the emergency department: predicting the need for subsequent intubation. Pediatr Emerg Care 2013;29:888-92.
29
Heikkilä P, Sokuri P, Mecklin M, Nuolivirta K, Tapiainen T, Peltoniemi O, et al. Using high-flow nasal cannulas for infants with bronchiolitis admitted to paediatric wards is safe and feasible. Acta Paediatr 2018;107:1971-6.
30
Shioji N, Iwasaki T, Kanazawa T, Shimizu K, Suemori T, Sugimoto K, et al. Physiological impact of high-flow nasal cannula therapy on postextubation acute respiratory failure after pediatric cardiac surgery: a prospective observational study. J Intensive Care 2017;5:35.
2024 ©️ Galenos Publishing House